- Who can participate: Adults aged 18 to 65 with a diagnosis of hypertension may be eligible. Key exclusions include those with secondary hypertension or recent cardiovascular events.
- Study details: Participants will receive either the investigational medication or a placebo, administered orally once daily. The placebo is an inactive substance designed to mimic the investigational treatment.

